drugset / Trial / NCT06357104

Detoxification From the Lipid Tract

NCT06357104

NaSingle-groupOpen-labelTreatment

Summary

Apart from electroencephalogram biofeedback and electrical brain stimulation adopted for maintenance treatment, the study utilizes ultra-low frequency transcranial magnetic stimulation (ULF-TMS) for initial γ-aminobutyric acid (GABA) stimulation. The cocktail therapy starts after the primary efficacy endpoint, and concomitant therapy is adopted throughout the study.

Timeline

Start
2024-02-26
Primary completion
2024-03-14
Completion
2024-03-20

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Alprazolam Small molecule 0.4 mg
Subject Clonazepam Small molecule 1 mg
Subject Metoprolol Other / unclassified 95 mg
Subject Olanzapine Small molecule 10 mg
Subject Pravastatin Small molecule 20 mg
Subject Sacubitril-Valsartan Unknown 100 mg
Subject Sertraline Small molecule 150 mg

Indications

No indication recorded.